Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Genvoya vs Truvada for PrEP in MSM and TGW
NCT02985996Phase 1Completed
- Sponsor
- Emory University
- Start
- Feb 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV) (5 arms), sponsored by Emory University. Primary endpoints: Intracellular Emtricitabine Triphosphate Concentration and Intracellular Tenofovir Diphosphate Concentration. Started Feb 2017; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02985996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985996.